AC Ludolph

1.0k total citations
22 papers, 577 citations indexed

About

AC Ludolph is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, AC Ludolph has authored 22 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in AC Ludolph's work include Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). AC Ludolph is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). AC Ludolph collaborates with scholars based in Germany, Austria and Italy. AC Ludolph's co-authors include Johannes Brettschneider, Axel Petzold, Hayrettin Tumani, Sigurd D. Süßmuth, Rudolf Happle, Gisela Bonsmann, J. Knop, E. Macher, Vincenzo Silani and Pamela J. Shaw and has published in prestigious journals such as Neurology, Electroencephalography and Clinical Neurophysiology and British Journal of Dermatology.

In The Last Decade

AC Ludolph

21 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AC Ludolph Germany 7 381 180 101 83 79 22 577
Guilhem Solé France 15 176 0.5× 94 0.5× 250 2.5× 119 1.4× 107 1.4× 62 731
Byung Kyu Cho South Korea 13 135 0.4× 206 1.1× 87 0.9× 34 0.4× 70 0.9× 30 493
N. C. Notermans Netherlands 12 506 1.3× 64 0.4× 58 0.6× 116 1.4× 77 1.0× 22 644
Rabab Debs France 12 237 0.6× 74 0.4× 114 1.1× 84 1.0× 26 0.3× 25 486
Arsalan Ahmad Pakistan 11 190 0.5× 92 0.5× 192 1.9× 71 0.9× 21 0.3× 57 568
R. Reñé Spain 14 941 2.5× 43 0.2× 160 1.6× 118 1.4× 49 0.6× 27 1.2k
Nicholas J. Silvestri United States 18 680 1.8× 49 0.3× 180 1.8× 79 1.0× 34 0.4× 52 1.1k
Hui Xiong China 17 130 0.3× 239 1.3× 652 6.5× 75 0.9× 50 0.6× 116 1.0k
P. D. Donofrio United States 10 740 1.9× 78 0.4× 156 1.5× 202 2.4× 19 0.2× 14 996
P Fleury Netherlands 14 126 0.3× 48 0.3× 214 2.1× 202 2.4× 67 0.8× 44 698

Countries citing papers authored by AC Ludolph

Since Specialization
Citations

This map shows the geographic impact of AC Ludolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AC Ludolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AC Ludolph more than expected).

Fields of papers citing papers by AC Ludolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AC Ludolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AC Ludolph. The network helps show where AC Ludolph may publish in the future.

Co-authorship network of co-authors of AC Ludolph

This figure shows the co-authorship network connecting the top 25 collaborators of AC Ludolph. A scholar is included among the top collaborators of AC Ludolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AC Ludolph. AC Ludolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenner, Dávid, Axel Freischmidt, AC Ludolph, & Jochen H. Weishaupt. (2020). Genspezifische Therapieansätze bei amyotropher Lateralsklerose in Gegenwart und Zukunft. Der Nervenarzt. 91(4). 287–293. 3 indexed citations
2.
Ludolph, AC & Claudia D. Wurster. (2018). Therapie der spinalen Muskelatrophie mit dem Antisense-Oligonukleotid Nusinersen. Nervenheilkunde. 37(3). 185–190. 1 indexed citations
3.
Lindner-Pfleghar, Beate, Hermann Neugebauer, Sebastian Stösser, et al.. (2017). Dysphagiemanagement beim akuten Schlaganfall. Der Nervenarzt. 88(2). 173–179. 4 indexed citations
4.
Braak, Heiko, Manuela Neumann, AC Ludolph, & Kelly Del Tredici. (2017). Does Sporadic Amyotrophic Lateral Sclerosis Spread via Axonal Connectivities?. 1(3). E136–E141. 14 indexed citations
5.
Nagel, Gabriele, et al.. (2012). Möglichkeiten register-basierter Studien zur Erforschung seltener Erkrankungen. Aktuelle Neurologie. 39(1). 12–17. 4 indexed citations
6.
Sperfeld, A.D, et al.. (2010). CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology. 74(12). 982–987. 62 indexed citations
8.
Brettschneider, Johannes, Longhou Fang, Corinna Hendrich, et al.. (2009). Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis. Aktuelle Neurologie. 36(S 02). 1 indexed citations
9.
Brettschneider, Johannes, et al.. (2009). FP57-FR-05 Prognostic markers in amyotrophic lateral sclerosis (ALS): proteome analysis of cerebrospinal fluid. Journal of the Neurological Sciences. 285. S148–S148. 1 indexed citations
10.
Brettschneider, Johannes, Axel Petzold, Sigurd D. Süßmuth, AC Ludolph, & Hayrettin Tumani. (2006). Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 66(6). 852–856. 200 indexed citations
11.
Ecker, D., Urban W. Geisthoff, Markus Juchems, et al.. (2005). Hereditäre hämorrhagische Teleangiektasie. Der Nervenarzt. 76(8). 980–983. 1 indexed citations
12.
Odin, Per, et al.. (2005). Efficacy and safety of high-dose cabergoline in Parkinson's disease. Acta Neurologica Scandinavica. 113(1). 18–24. 19 indexed citations
13.
Tumani, Hayrettin, et al.. (2002). Die klinisch atypische CJK - Diagnostische Bedeutung von Liquormarkern und molekulargenetischen Untersuchungen? -. DMW - Deutsche Medizinische Wochenschrift. 127(7). 318–320. 10 indexed citations
14.
Borasio, Gian Domenico, et al.. (2001). Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2(3). 159–164. 87 indexed citations
15.
Sperfeld, AD, G. Vietzke, Franz X. Kleber, & AC Ludolph. (1999). Die Spiroergometrie in der Diagnostik mitochondrialer Erkrankungen. Der Nervenarzt. 70(2). 155–161. 2 indexed citations
16.
Bachus, R., et al.. (1997). Molekularbiologische Befunde bei der amyotrophen Lateralsklerose. Der Nervenarzt. 68(10). 785–791.
17.
Ludolph, AC, et al.. (1989). Die elektromagnetische Stimulation des Nervensystems - I. Normwerte im zentralen Nervensystem und Vergleich mit der elektrischen Stimulation. Klinische Neurophysiologie. 20(3). 153–158. 5 indexed citations
18.
Ludolph, AC, et al.. (1983). Electrophysiological studies concerning the reversibility of polyneuropathies due to thalidomide therapy of lupus erythematodes discoides. Electroencephalography and Clinical Neurophysiology. 56(3). S128–S128. 1 indexed citations
19.
Ludolph, AC, et al.. (1982). Elektrophysiologische Veränderungen bei Thalidomid-Neuropathie unter Behandlung des Lupus erythematodes discoides. Klinische Neurophysiologie. 13(4). 167–170. 4 indexed citations
20.
Ludolph, AC, et al.. (1982). [Electrophysiologic changes in thalidomide neuropathy in the treatment of discoid lupus erythematosus].. PubMed. 13(4). 167–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026